Desq Long
Sign in
SEC FORM 4
$189,390.60

Oric Pharmaceuticals, Inc. (ORIC)

Sale of 14,000 shares at $13.5279 per share.

Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001695028-26-000012 · filed 2026-10-21 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Oric Pharmaceuticals, Inc. (ORIC)." Disclosed 2026-10-21. https://desqlong.com/cards/0001695028-26-000012-2 (retrieved 2026-10-22).